Mauricio Silva Almeida Ribeiro, MD
Mauricio Silva Almeida Ribeiro, MD
Specialty: Medical Oncology
Program: Sarcoma
Language(s): English
-
Overview
Cancer Focus:
GIST (Gastrointestinal Stromal Tumor), Osteosarcoma, SarcomaDr. Ribeiro is a Medical Oncologist and Assistant Member at the Sarcoma Department. He received his MD degree and completed an Internal Medicine residency at the Sao Paulo State University in Botucatu/Sao Paulo, Brazil. He then completed a Medical Oncology fellowship at Hospital Sírio-Libanês, in São Paulo, where he continued working as a Medical Oncologist until he moved to Canada in 2021.Subsequently, Dr. Ribeiro completed a Clinical Research Fellowship in Sarcoma/Cutaneous Oncology at the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, University of Toronto, Canada. Dr. Ribeiro’s clinical interest focus on providing care to adult soft-tissue sarcoma patients, mostly those diagnosed with liposarcoma, leiomyosarcoma, GIST, and desmoid-type fibromatosis. His particularly interested radiation-associated sarcomas, synovial sarcoma, and desmoid-type fibromatosis clinical and database research. He is member of the following professional societies: American Society of Clinical Oncology, European Society of Medical Oncology, Connective Tissue Oncology Society, Transatlantic Australasian Retroperitoneal Sarcoma Working Group, Brazilian Society of Clinical Oncology, and the Brazilian Sarcoma Group.
-
Publications
- Ribeiro MF, Peretz Soroka H, Bhura Z, Hirsch I, Wunder J, Ferguson P, Tsoi K, Brar S, Gladdy R, Swallow C, Chung P, Catton C, Wong P, Watson G, Razak ARA, Gupta AA, Shultz D. Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study. Ther Adv Med Oncol. 2023 Sep.15. Pubmedid: 37781501. Pmcid: PMC10540571.
- Kibel S, Kuehne N, Ribeiro MF, Muniz TP, Ye XY, Spreafico A, Saibil SD, Sun A, Mak DY, Gray D, Jones B, Wong P, Butler MO. The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers (Basel). 2023 Dec.15(24). Pubmedid: 38136412. Pmcid: PMC10741555.
-
Patient Comments
41 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments